748 related articles for article (PubMed ID: 16574357)
1. Physicochemical characteristics and bioavailability of a novel intestinal metabolite of ginseng saponin (IH901) complexed with beta-cyclodextrin.
Lee PS; Han JY; Song TW; Sung JH; Kwon OS; Song S; Chung YB
Int J Pharm; 2006 Jun; 316(1-2):29-36. PubMed ID: 16574357
[TBL] [Abstract][Full Text] [Related]
2. Effect of beta-cyclodextrin and hydroxypropyl beta-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir.
Aleem O; Kuchekar B; Pore Y; Late S
J Pharm Biomed Anal; 2008 Jul; 47(3):535-40. PubMed ID: 18367363
[TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of inclusion complexes of prazosin hydrochloride with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
Liu L; Zhu S
J Pharm Biomed Anal; 2006 Jan; 40(1):122-7. PubMed ID: 16095859
[TBL] [Abstract][Full Text] [Related]
5. Study of freeze-dried quercetin-cyclodextrin binary systems by DSC, FT-IR, X-ray diffraction and SEM analysis.
Pralhad T; Rajendrakumar K
J Pharm Biomed Anal; 2004 Feb; 34(2):333-9. PubMed ID: 15013147
[TBL] [Abstract][Full Text] [Related]
6. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
7. Preformulation study of the inclusion complex warfarin-beta-cyclodextrin.
Zingone G; Rubessa F
Int J Pharm; 2005 Mar; 291(1-2):3-10. PubMed ID: 15707726
[TBL] [Abstract][Full Text] [Related]
8. Solid-state characterization and dissolution properties of bicalutamide-beta-cyclodextrin inclusion complex.
Patil AL; Pore YV; Kuchekar BS; Late SG
Pharmazie; 2008 Apr; 63(4):282-5. PubMed ID: 18468387
[TBL] [Abstract][Full Text] [Related]
9. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.
Figueiras A; Carvalho RA; Ribeiro L; Torres-Labandeira JJ; Veiga FJ
Eur J Pharm Biopharm; 2007 Sep; 67(2):531-9. PubMed ID: 17451924
[TBL] [Abstract][Full Text] [Related]
10. Preparation, characterization and in vivo evaluation of formulation of baicalein with hydroxypropyl-beta-cyclodextrin.
Liu J; Qiu L; Gao J; Jin Y
Int J Pharm; 2006 Apr; 312(1-2):137-43. PubMed ID: 16459034
[TBL] [Abstract][Full Text] [Related]
11. Analysis of triclosan inclusion complexes with β-cyclodextrin and its water-soluble polymeric derivative.
Jug M; Kosalec I; Maestrelli F; Mura P
J Pharm Biomed Anal; 2011 Apr; 54(5):1030-9. PubMed ID: 21215544
[TBL] [Abstract][Full Text] [Related]
12. Inclusion complexes of noscapine in beta-cyclodextrin offer better solubility and improved pharmacokinetics.
Madan J; Dhiman N; Parmar VK; Sardana S; Bharatam PV; Aneja R; Chandra R; Katyal A
Cancer Chemother Pharmacol; 2010 Feb; 65(3):537-48. PubMed ID: 19597818
[TBL] [Abstract][Full Text] [Related]
13. The influence of the preparation methods on the inclusion of model drugs in a beta-cyclodextrin cavity.
Salústio PJ; Feio G; Figueirinhas JL; Pinto JF; Cabral Marques HM
Eur J Pharm Biopharm; 2009 Feb; 71(2):377-86. PubMed ID: 18977436
[TBL] [Abstract][Full Text] [Related]
14. Solubility enhancement of celecoxib using beta-cyclodextrin inclusion complexes.
Rawat S; Jain SK
Eur J Pharm Biopharm; 2004 Mar; 57(2):263-7. PubMed ID: 15018983
[TBL] [Abstract][Full Text] [Related]
15. Lyophilization monophase solution technique for improvement of the physicochemical properties of an anticancer drug, flutamide.
Elgindy N; Elkhodairy K; Molokhia A; Elzoghby A
Eur J Pharm Biopharm; 2010 Feb; 74(2):397-405. PubMed ID: 19944160
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo evaluation of an amylobarbitone/hydroxypropyl-beta-cyclodextrin complex prepared by a freeze-drying method.
Fathy M; Sheha M
Pharmazie; 2000 Jul; 55(7):513-7. PubMed ID: 10944779
[TBL] [Abstract][Full Text] [Related]
17. Eudragit RS 100 microparticles containing 2-hydroxypropyl-beta-cyclodextrin and glutathione: physicochemical characterization, drug release and transport studies.
Trapani A; Laquintana V; Denora N; Lopedota A; Cutrignelli A; Franco M; Trapani G; Liso G
Eur J Pharm Sci; 2007 Jan; 30(1):64-74. PubMed ID: 17118631
[TBL] [Abstract][Full Text] [Related]
18. Physicochemical characteristics and oral bioavailability of andrographolide complexed with hydroxypropyl-beta-cyclodextrin.
Ren K; Zhang Z; Li Y; Liu J; Zhao D; Zhao Y; Gong T
Pharmazie; 2009 Aug; 64(8):515-20. PubMed ID: 19746840
[TBL] [Abstract][Full Text] [Related]
19. Hydroxypropyl-beta-cyclodextrin-flutamide inclusion complex. II. Oral and intravenous pharmacokinetics of flutamide in the rat.
Zuo Z; Tam YK; Diakur J; Wiebe LI
J Pharm Pharm Sci; 2002; 5(3):292-8. PubMed ID: 12553899
[TBL] [Abstract][Full Text] [Related]
20. Dissolution properties and characterization of halofantrine-2-hydroxypropyl-beta-cyclodextrin binary systems.
Onyeji CO; Omoruyi SI; Oladimeji FA
Pharmazie; 2007 Nov; 62(11):858-63. PubMed ID: 18065103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
